Auxilium Health develops technology focused on improving patient wound care outcomes. The company provides solutions designed to streamline the healing process for individual patients. Their focus is on delivering smarter, more efficient wound management strategies.
Funding
$1.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Chronic wounds, such as diabetic ulcers and pressure sores, pose significant challenges due to their slow healing rates and susceptibility to infection. Current wound care solutions often fail to adequately address these issues, leading to prolonged treatment times and increased healthcare costs.
Solution
Auxilium Health develops advanced biomaterials designed to accelerate the healing process and monitor for infections in chronic wounds. Their technology aims to provide a smarter way to heal wounds, potentially reducing treatment time and improving patient outcomes. The biomaterials are engineered to promote tissue regeneration and provide a protective barrier against microbial invasion. By actively monitoring the wound environment, the technology enables early detection of infections, allowing for timely intervention and preventing complications.
Target Audience
The primary target audience includes patients suffering from chronic wounds, healthcare providers specializing in wound care, and hospitals seeking advanced treatment options.
Features
- Advanced biomaterials that promote tissue regeneration
- Integrated infection monitoring capabilities for early detection
- Enhanced wound protection against microbial contamination
- Potential for reduced treatment times and improved healing rates